[1] Collaborators G B O D S. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J] . Lancet, 2015, 386(9995): 743-800. [2] 何泽民, 何勇强, 吕放光, 等. 全面构建大学生心理危机预防与干预体系[J] . 邵阳学院学报(自然科学版), 2018, 15(3): 97-103. [3] Duman RS, Li N, Liu RJ, et al. Signaling pathways underlying the rapid antidepressant actions of ketamine[J] . Neuropharmacology, 2012, 62(1): 35-41. [4] Han L, Luo H, Huang F, et al. Apelin-13 impaires acquisition but not consolidation or expression of contextual fear in rats[J] . Neurochemical Research, 2016, 41(9): 2345-2351. [5] Lv SY, Qin YJ, Wang HT, et al. Centrally administered apelin-13 induces depression-like behavior in mice[J] . Brain Research Bulletin, 2012, 88(6): 574-580. [6] Li E, Deng H, Wang B, et al. Apelin-13 exerts antidepressant-like and recognition memory improving activities in stressed rats[J] . Eur Neuropsychopharmacol, 2016, 26(3): 420-430. [7] Zanos P, Moaddel R, Morris PJ, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites[J] . Nature, 2016, 533(7604): 481-486. [8] O'carroll AM, Lolait SJ, Harris LE, et al. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis[J] . J Endocrinol, 2013, 219(1): R13-35. [9] Cao J, Li H, Chen L. Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases[J] . Current Drug Targets, 2015, 16(2): 148-155. [10] Xiong Q, He W, Wang H, et al. Effect of the spinal apelin APJ system on the pathogenesis of chronic constriction injury induced neuropathic pain in rats[J] . Molecular Medicine Reports, 2017, 16(2): 1223-1231. [11] Wang K, Ju Z, Yong Y, et al. The effects of electroacupuncture on the Apelin/APJ system in the spinal cord of rats with inflammatory pain[J] . Anesth Analg, 2016, 123(6): 1603-1610. [12] Xin Q, Cheng B, Pan Y, et al. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation[J] . Peptides, 2015, 63(5): 55-62. [13] Chen D, Lee J, Gu X, et al. Intranasal delivery of Apelin-13 is neuroprotective and promotes angiogenesis after ischemic stroke in mice[J] . ASN Neuro, 2015, 7(5): 23-31. [14] Fan J, Ding L, Xia D, et al. Amelioration of apelin-13 in chronic normobaric hypoxia-induced anxiety-like behavior is associated with an inhibition of NF-kappaB in the hippocampus[J] . Brain Research Bulletin, 2017, 130(2): 67-74. [15] 邓海峰. Apelin-13抗抑郁效应研究[D] . 南华大学, 2011. [16] Zhang JC, Yao W, Dong C, et al. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression[J] . Psychopharmacology, 2015, 232(23): 4325-4335. [17] Taheri S, Murphy K, Cohen M, et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats[J] . Biochem Biophys Res Commun, 2002, 291(5): 1208-1212. [18] Newson MJ, Pope GR, Roberts EM, et al. Stress-dependent and gender-specific neuroregulatory roles of the apelin receptor in the hypothalamic-pituitary-adrenal axis response to acute stress[J] . J Endocrinol, 2013, 216(1): 99-109. [19] Ustunel I, Acar N, Gemici B, et al. The effects of water immersion and restraint stress on the expressions of apelin, apelin receptor (APJR) and apoptosis rate in the rat heart[J] . Acta Histochemica, 2014, 116(5): 675-681. [20] 戴婷婷. Apelin-13通过BDNF调控海马GR核转位改善慢性应激诱导大鼠抑郁行为[D] . 南华大学, 2016. [21] Machado-Vieira R, Henter ID, Zarate CA, Jr. New targets for rapid antidepressant action[J] . Prog Neurobiol, 2017, 152(5): 21-37. [22] Xue W, Wang W, Gong T, et al. PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine[J] . Scientific Reports, 2016, 6(1): 26-33. |